FDA’s May 2014 draft guidance on FoB’s (18 pages): http://t.co/bnqAgAQaqb Additional color from FierceBiotech: http://www.fiercebiotech.com/story/fda-breaks-silence-biosimilars-long-awaited-proposal/2014-05-14#ixzz31i4bPyry